Solid Renal Cell Carcinoma in a Dog

Authors

DOI:

https://doi.org/10.22456/1679-9216.139521

Keywords:

Neoplasia, Renal cell carcinoma, Nephrectomy, chemotherapy, dog

Abstract

Background: Renal cell carcinoma (RCC) is the most important renal neoplasm found in dogs and cats when compared to metastatic or multicentric ones. This malignant epithelial neoplasm affects frequently middle-aged males, whit reserved prognosis. The present study aimed to report a study case about a male dog histologically diagnosed with solid RCC, treated by unilateral nephroureterectomy.

Case: A 8-year-old, male, mixed-breed , castrated dog with 20.4 kg was treated at the “Cães, Gatos & Cia Clinic” in Brusque city, state of Santa Catarina, Brazil. The animal showed acute abdominal pain and hematuria. Abdominal ultrasound (AU), thorax radiograph, complete blood count (CBC), serum biochemistry and urinalysis were also performed. Urinalysis demonstrated brown, turbid and alkaline pH (8) urine, with slightly low density (1,010) containing erythrocytes (> 200,000/mL) and leukocytes (116,000/mL) cells, including degenerated neutrophils and macrophages, and also moderate bacterial flora and few transitional cells. AU revealed a hypoechoic and heterogeneous nodular structure formed by cavitary regions, free fluid and peritonitis areas on the right kidney’s topography were identified too, while radiograph image evidenced a well-defined mass, measuring approximately 8.5 cm. After imaging exams, the exploratory celiotomy executed resulted in the remotion of the malign structure, considering the appropriate safety margin, followed by histopathological examination. The full procedure consisted in the right unilateral nephroureterectomy, and subsequent postoperative care chemotherapy with carboplatin, piroxicam, omega-3 and probiotics supplementation. Neoplastic cells with mantle arrangement were distinguished forming small interspersed groups for thin trabeculae of fibrovascular tissue. These cells exhibited polyhedric shape, distinct cellular boundaries, round or oval central nuclei (loose chromatin with up to 2 small basophilic nucleoli), and a large amount of eosinophilic cytoplasm. Mitotic forms were also observed, moderate pleomorphism and no atypia. These observations were compatible with solid RCC, suggesting immunohistochemical analysis.

Discussion: RCC is a malign and frequent neoplasm in middle-aged male dogs, with nonspecific clinical signs and laboratory test results (CBC and serum biochemistry) making it difficult to diagnose, therefore image exams are essentials to support neoplasia hypothesis. On the other hand, fine needle aspiration, ultrasound-guided or exploratory celiotomy biopsies followed by histopathological examination can also be used; in the present case, the latter was chosen. Furthermore, immunohistochemistry is essential as diagnosis tool to determine RCC cytological or molecular nature. Hence, in cases of unilateral RCC, in which there is no impairment of renal function and metastasis, the treatment is unilateral nephroureterectomy and post-surgical chemotherapy, in addition to palliative care aimed at the patient's welfare. Despite the given instructions offered to the tutor, about immunohistochemistry and chemotherapy importance for patient diagnosis and prognosis, negative response was perceived. As in the present study case, as well as in others, after surgical removal; pursuit of the patient's wellbeing would ensure that the healthy kidney maintained its functions, and also monitor possible metastases emergence. In fact, this and other struggles are faced by veterinarians in Brazil convincing tutors to perform complementary exams and treatments, considered expensive. Such behavior indicates that many patients who could have better and favorable prognosis or longer life span, after being diagnosed and treated for neoplasms, do not have this opportunity.

Keywords: dog, neoplasia, renal cell carcinoma, nephrectomy, chemotherapy.

Título: Carcinoma de células renais sólido em cão

Descritores: cão, neoplasia, carcinoma renal, nefrectomia, quimioterapia.

Downloads

Download data is not yet available.

References

Athanazio D.A., Amorim L.S., Cunha I.W., Leite K.R.M., Paz A.R., Gome R.P.X., Tavora F.R.F., Faraj S.F., Cavalcanti M.S. & Bezerra S.M. 2021. Classification of renal cell tumors – current concepts and use of ancillary tests: recommendations of the brazilian society of pathology. Surgical and Experimental Pathology. 4: 1-21. DOI: 10.1186/s42047-020-00084-x. DOI: https://doi.org/10.1186/s42047-020-00084-x

Bennett F. 2004. Unilateral renal cell carcinoma in a Labrador retriever. Canadian Veterinary Journal. 45(10): 860-862.

Coffee C., Roush J.K. & Higginbotham M.L. 2020. Carboplatin‐induced myelosuppression as related to body weight in dogs. Veterinary and Comparative Oncology. 18(4): 804-810. DOI: 10.1111/vco.12622. DOI: https://doi.org/10.1111/vco.12622

Daleck C.R. & Nardi A.B. 2016. Neoplasias do Sistema Urinário. In: Carvalho M.A., Brum A.M., Vasconcellos A.L. & Alves M.A.M.K. (Eds). Oncologia em Cães e Gatos. 2.ed. Rio de Janeiro: Roca, pp.675-684.

Dourado B.S.M., Biaggi A., Roque B., Almeida F.M., Shigeo R. & Medina A.M. 2021. Carcinoma renal bem diferenciado, padrão papilar em cão: relato de caso. Pubvet. 15(4): 1-5. DOI: 10.31533/pubvet.v15n04a788.1-5. DOI: https://doi.org/10.31533/pubvet.v15n04a788.1-5

Edmondson E.F., Hess A.M. & Powers B.E. 2014. Prognostic Significance of Histologic Features in Canine Renal Cell Carcinomas. Veterinary Pathology. 52(2): 260-268. DOI: 10.1177/0300985814533803. DOI: https://doi.org/10.1177/0300985814533803

Eichstadt L.R., Moore G.E. & Childress M.O. 2016. Risk factors for treatment‐related adverse events in cancer‐bearing dogs receiving piroxicam. Veterinary and Comparative Oncology. 15(4): 1346-1353. DOI: 10.1111/vco.12276. DOI: https://doi.org/10.1111/vco.12276

Fossum T.W. 2014. Cirurgia dos Rins e Ureteres. In: Fossum T.W. (Ed). Cirurgia de Pequenos Animais. 4.ed. Rio de Janeiro: Elsevier, pp.705-732.

Gong D., Sun Y., Guo C., Sheu T., Zhai W., Zheng J. & Chang C. 2021. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis. Clinical And Translational Medicine. 11(3): 1-19. DOI: 10.1002/ctm2.353. DOI: https://doi.org/10.1002/ctm2.353

Lee G.T., Han C., Kwon Y.S., Patel R., Modi P.K., Kwon S.J., Faiena I., Patel N., Singer E. & Ahn H. 2017. Intracrine androgen biosynthesis in renal cell carcinoma. British Journal of Cancer. 116(7): 937-943. DOI: 10.1038/bjc.2017.42. DOI: https://doi.org/10.1038/bjc.2017.42

Lima V.S. 2020. A uroanálise no diagnóstico de doenças renais: aspectos abordados nas análises físico-químicas e sedimentoscópica. Revista Brasileira de Educação e Saúde. 3(10): 42-49. DOI: 10.18378/rebes.v10i3.7876.

Marques F.S., Silva A.L.M. & Couto R.D. 2015. Dislipidemia associada à doença renal crônica – Revisão de literatura. Revista de Ciências Médicas e Biológicas. 13(2): 220-225. DOI: 10.9771/cmbio.v13i2.12444. DOI: https://doi.org/10.9771/cmbio.v13i2.12444

Meuten D.J. & Meuten T.L.K. 2017. Tumors of the Urinary System. In: Meuten D.J. (Ed). Tumors in Domestic Animals. 5th edn. Ames: John Wiley & Sons Inc., pp.632-688. DOI: https://doi.org/10.1002/9781119181200.ch15

Meyer P.M. 2015. Neoplasias de riñón, uréteres y vejiga. In: XV Congresso Nacional de Aveaca (Buenos Aires, Argentina), pp.50-52.

Minuzzo T., Silveira S.D., Batschke C.F., Correa F.L. & Agostini P. 2020. Uso de eritropoietina recombinante humana em um cão com doença renal crônica: relato de caso. Pubvet. 14(11): 1-6. DOI: 10.31533/pubvet.v14n11a687.1-6. DOI: https://doi.org/10.31533/pubvet.v14n11a687.1-6

Nyland T.G. & Mattoon J.S. 2005. Trato Urinário. In: Nyland T.G. & Mattoon J.S. (Eds). Ultrassom Diagnóstico em Pequenos Animais. 2.ed. São Paulo: Roca, pp.161-198.

Paça A.S. & Lazar M. 2013. A case report of renal cell carcinoma in a dog. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. 65(5): 1286-1290. DOI: 10.1590/s0102-09352013000500004. DOI: https://doi.org/10.1590/S0102-09352013000500004

Rawat P.S., Jaiswal A., Khurana A., Bhatti J.S. & Navik U. 2021. Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomedicine & Pharmacotherapy. 139: 111708. DOI: 10.1016/j.biopha.2021.111708. DOI: https://doi.org/10.1016/j.biopha.2021.111708

Reuter V.E. & Tickoo S.K. 2010. Differential diagnosis of renal tumours with clear cell histology. Pathology. 42(4): 374-383. DOI: 10.3109/00313021003785746. DOI: https://doi.org/10.3109/00313021003785746

Stupak E.C., Mariani O.M., Rezende L.R., Barros J.C., Magalhães L.F., Alexandre N.A., Costa M.L., Carvalho L.L., Magalhães G.M. & Calazans S.G. 2017. Carcinoma Renal Sólido em cadela: Relato de Caso. Investigação. 16(5): 1-44. DOI: 10.26843/investigacao.v16i5.1909.

Ubukata R. & Lucas S.R.R. 2015. Neoplasias do Sistema Urinário | Rins e Bexiga. In: Jericó M.M. & Kogika M.M. (Eds). Tratado de Medicina Interna de Cães e Gatos. Rio de Janeiro: Roca, pp.4494-4512.

Additional Files

Published

2024-09-05

How to Cite

Coury Santos, L. B., Kistenmacher de Bem, G., Dalcol Mazaro, R. D. M., & Martinez Pereira, M. A. (2024). Solid Renal Cell Carcinoma in a Dog. Acta Scientiae Veterinariae, 52. https://doi.org/10.22456/1679-9216.139521

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.